First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
Background This study assessed dolutegravir pharmacokinetics in HIV-infected infants receiving [...]
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Background This study evaluated the pharmacokinetics of dolutegravir in HIV-infected [...]
EMPIRICAL Annual Meeting
We are pleased to share an update from our ongoing [...]
